Salem Oaks Consulting
www.salemoaks.comWe are committed to working with patients, their advocates, biopharmaceutical companies, regulators and other stakeholders to develop educational tools that help patients bridge the gap between themselves and Biopharma R&D. Our Mission Helping bridge the gap between patients and caregivers, healthcare professionals and research-focused biopharmaceutical companies, so that they can achieve their shared objective of developing better treatment options for a wide range of diseases. Our Purpose Patients are becoming a more central part of the planning, execution, and interpretation of clinical studies. As clinical trials become more patient-centric, Pharmaceutical Companies and other trial sponsors are seeking to tap into the insights of those battling a disease. However, most patients are ill-equipped to engage optimally with the clinical trials process. Correspondingly, as newly diagnosed patients mature into patient advocates, there are few resources available for them to learn about clinical trials and drug development at a level deep enough for them to effectively influence the design of trials and even new therapies. Salem Oaks’ immediate objective is to build a suite of educational products that will close this educational gap. Salem Oaks hopes to provide off-the-shelf and customized products and services to patient advocacy groups that they can use to strengthen their members' ability to shape and accelerate the development of new medicines. These products and services may also be interesting to biopharmaceutical companies and other parties.
Read moreWe are committed to working with patients, their advocates, biopharmaceutical companies, regulators and other stakeholders to develop educational tools that help patients bridge the gap between themselves and Biopharma R&D. Our Mission Helping bridge the gap between patients and caregivers, healthcare professionals and research-focused biopharmaceutical companies, so that they can achieve their shared objective of developing better treatment options for a wide range of diseases. Our Purpose Patients are becoming a more central part of the planning, execution, and interpretation of clinical studies. As clinical trials become more patient-centric, Pharmaceutical Companies and other trial sponsors are seeking to tap into the insights of those battling a disease. However, most patients are ill-equipped to engage optimally with the clinical trials process. Correspondingly, as newly diagnosed patients mature into patient advocates, there are few resources available for them to learn about clinical trials and drug development at a level deep enough for them to effectively influence the design of trials and even new therapies. Salem Oaks’ immediate objective is to build a suite of educational products that will close this educational gap. Salem Oaks hopes to provide off-the-shelf and customized products and services to patient advocacy groups that they can use to strengthen their members' ability to shape and accelerate the development of new medicines. These products and services may also be interesting to biopharmaceutical companies and other parties.
Read moreCountry
State
Connecticut
Industry
Employees
1-10
Founded
2017
Social
Employees statistics
View all employeesPotential Decision Makers
Founder
Email ****** @****.comPhone (***) ****-****Owner and Director
Email ****** @****.comPhone (***) ****-****Principal Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(25)